10-Q: American Fusion Reports Q3 2026 Results, Faces Going Concern Doubt

American Fusion, Inc. filed its Q3 2026 Form 10-Q, detailing operational progress and financial condition, including a significant accumulated deficit and ongoing concerns about its ability to continue as a going concern.

Summary

• American Fusion, Inc. (AMFN) filed its quarterly report for the period ended September 30, 2026.
• The company reported a net loss of $1,436,076 for the three months ended September 30, 2026, and $2,800,078 for the nine months ended September 30, 2026.
• As of September 30, 2026, the company had an accumulated deficit of approximately $10.8 million and recurring operating losses, raising substantial doubt about its ability to continue as a going concern.
• The company received a Certificate of Registration from the Texas Department of State Health Services for industrial radiation machines for research and development activities.
• Significant legal and consulting expenses were incurred, including a $710,557 litigation liability.
• The company is actively pursuing capital-raising activities to fund operations.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to significant accumulated deficits, recurring operating losses, and substantial doubt about the company's ability to continue as a going concern, despite some recent operational milestones.

Positives

• Received Certificate of Registration No. R54726 from the Texas Department of State Health Services for research and development activities related to its Texatron Fusion Engine.
• Completed a reverse recapitalization with Kepler Fusion Technologies Inc. on February 27, 2026, integrating its assets and technology.
• Generated $58,000 in revenue for the nine months ended September 30, 2026, primarily from a new customer.
• Secured $1,551,000 in cash from financing activities during the nine months ended September 30, 2026, through prepaid warrants and unit sales.

Negatives

• Reported a net loss of $1,436,076 for Q3 2026 and $2,800,078 for the first nine months of 2026.
• Accumulated deficit of approximately $10.8 million as of September 30, 2026.
• Recurring operating losses raise substantial doubt about the company's ability to continue as a going concern.
• A material weakness in internal control over financial reporting was identified due to insufficient accounting personnel with expertise in complex transactions.
• Significant litigation liability of $710,557 as of September 30, 2026.
• Convertible notes payable, related party, totaling $506,890 were in default as of September 30, 2026.

Risks

• The company's ability to continue as a going concern is subject to substantial doubt due to accumulated deficits and recurring operating losses.
• Management believes planned capital-raising activities will provide necessary resources, but there is no assurance these plans will succeed.
• The utilization of net operating loss carryforwards may be limited under IRC Section 382 due to a change in control.
• Certain securities purchase agreements contain dilutive issuance protection provisions and price protection true-up provisions that could lead to additional share issuances.
• The company is in an early stage of development with limited operating history and may require substantial additional capital to fund operations and commercialization.
• The registration for industrial radiation machines authorizes research and development activities only and does not constitute certification of technology or commercial performance.

Future Outlook

The company expects to require substantial additional capital to fund its research and development activities, prototype testing, intellectual property filings, and preparation for commercial deployment. Management is actively pursuing financing opportunities, including a previously announced $50 million capital raise.

Management Comments

• Management believes that planned capital-raising activities will provide the resources needed to fund ongoing operations. There can be no assurance that these plans will succeed.
• Management concluded that the error identified in previously issued interim financial statements was not material to those statements when considering all relevant qualitative and quantitative factors, and therefore a restatement was not required.
• Management believes receipt of the Texas Department of State Health Services registration represents a significant operational milestone supporting continued engineering, prototype testing, technical validation, and research activities.

Industry Context

StockSavvy.ai notes that American Fusion operates in the nascent but potentially transformative fusion energy sector. The company's focus on the Texatron compact pulsed toroidal fusion reactor places it among a group of companies seeking to commercialize fusion power. The significant capital requirements and long development timelines are characteristic of this industry, as is the reliance on government registrations and regulatory approvals for R&D activities.

Comparison to Industry Standards

• The company's accumulated deficit of $10.8 million and recurring operating losses are common for early-stage fusion energy companies, which require substantial investment before generating significant revenue.
• The reliance on equity issuances and related-party loans for funding is typical for companies in capital-intensive, long-term development phases, though the current financial position raises going concern issues.
• The development of prototype fusion reactors, such as the Texatron Version 9, aligns with industry efforts to achieve viable fusion power generation, though specific performance benchmarks are not yet detailed.
• The regulatory registration for industrial radiation machines is a necessary step for R&D in this field, similar to requirements faced by other advanced energy research entities.

Management Changes

Corporate Governance

Legal Proceedings

• The company is actively pursuing legal remedies to vacate a judgment entered against it by the Court of Alaska on December 12, 2024, for $618,994 plus interest, on the grounds that the underlying asset purchase agreement was never consummated.
• In April 2026, the Company obtained an amended default judgment rescinding legacy asset purchase agreements and canceling the prior issuance of 1,683,000,000 shares of common stock.

Related Party Transactions

• Consulting agreement with Brent Nelson (CEO) for $15,000 per month, with potential for additional compensation.
• Consulting agreement with RH2 Equity Partners, LP (controlled by Richard C. Hawkins and Robert Hymers) for cash fees, retention of outstanding notes, and issuance of 1,000,000 common shares vesting over 36 months.
• Settlement and Exchange Agreements with CMB Communications LLC and Pinnacle Consulting Services, Inc. to convert approximately $500,000 of indebtedness into 1,000,000 common shares.
• Issuance of prepaid warrants to Pinnacle Consulting Services Inc. for $1,389,000 in cash proceeds.
• Officer consulting and independent director advisory agreements totaling $102,000 and $204,000 for the three and nine months ended September 30, 2026, respectively.
• Conversion of $24,999 of principal and accrued interest from convertible notes payable by Pinnacle Consulting Services, Inc. into 125,000,000 shares of common stock during the nine months ended September 30, 2026.
• Subsequent to period end, Pinnacle Consulting Services, Inc. converted $6,000 of principal and accrued interest into 30,000,000 shares of common stock on October 1, 2026.

Stakeholder Impact

• Shareholders: Dilution risk from potential future capital raises and conversion of outstanding notes and warrants. The material weakness in internal controls could impact investor confidence.
• Creditors: Convertible notes payable related party were in default as of September 30, 2026.
• Employees/Consultants/Directors: Significant portion of compensation is stock-based, with potential for future dilution. Changes in executive leadership may impact morale and strategic direction.
• Suppliers: No specific impact mentioned, but ongoing operations depend on continued funding.

Next Steps

• Continue research and development, prototype testing, and intellectual property expansion.
• Prepare for commercial deployment of the Texatron fusion reactor.
• Pursue planned capital-raising activities to fund ongoing operations.
• Implement remediation plan to address the material weakness in internal control over financial reporting.
• Complete a Section 382 study regarding the utilization of net operating loss carryforwards.

Key Dates

Recommendation

The company shows progress in R&D and regulatory milestones, but the significant accumulated deficit, recurring losses, and going concern doubt present substantial risks. The recent capital raises and convertible note issuances indicate a need for funding, which could lead to dilution. While the technology is promising, the path to commercialization and profitability is uncertain, warranting a hold recommendation pending clearer signs of financial stability and operational execution.

Keywords

fusion energy, Texatron, quarterly report, financial statements, going concern, reverse recapitalization, stock-based compensation, convertible notes